Literature DB >> 11202757

Psychometric properties of the VSQLQ in black patients with mild hypertension. Vital Signs Quality of Life Questionnaire.

N K Leidy1, J K Schmier, A E Bonomi, M Legro, T Zyczynski, B W Kong.   

Abstract

The Vital Signs Quality of Life Questionnaire (VSQLQ) is a condition- and culture-specific measure designed to assess health-related quality of life (HRQL) in black patients with hypertension. This study examined the instrument's reliability and validity when administered via personal interview to patients with mild systemic hypertension. Data were gathered from 304 black patients during the screening visit of a multicenter trial evaluating the efficacy of candesartan cilexetil (ATACAND). In addition to internal consistency and reproducibility, validity was assessed by correlating the VSQLQ with the Short Form-36 (SF-36). Sensitivity to sociodemographic effects and responsiveness to change was also examined. Cronbach's alpha levels were high (0.90, 0.92, 0.92 for frequency, intensity and combined scores, respectively) and the instrument was stable in patients reporting no health change over 8 weeks (ICC = 0.79, 0.79, and 0.80). Correlations between the VSQLQ and the SF-36 were moderate to high (0.32 to - 0.69) and statistically significant (p < 0.001). VSQLQ scores varied by gender, education, and income (p < 0.05). Patients who reported improvement in their general health status also reported significant improvements on the VSQLQ (n = 90; p < 0.05). Results support the reliability and validity of VSQLQ administered via personal interview to black patients with mild systemic hypertension.

Entities:  

Mesh:

Year:  2000        PMID: 11202757      PMCID: PMC2568336     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  24 in total

1.  Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise?

Authors:  P Hjemdahl; I K Wiklund
Journal:  J Hypertens       Date:  1992-12       Impact factor: 4.844

2.  Measurement of health status. Ascertaining the minimal clinically important difference.

Authors:  R Jaeschke; J Singer; G H Guyatt
Journal:  Control Clin Trials       Date:  1989-12

3.  A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension.

Authors:  A J Lewin; M C Lueg; S Targum; P Cardenas
Journal:  Clin Cardiol       Date:  1993-10       Impact factor: 2.882

4.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

Review 5.  Quality of life and the heart: evaluation of therapeutic alternatives.

Authors:  C J Bulpitt; A E Fletcher
Journal:  Br J Clin Pract Suppl       Date:  1994-05

6.  The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

Authors:  D G Fryback; E J Dasbach; R Klein; B E Klein; N Dorn; K Peterson; P A Martin
Journal:  Med Decis Making       Date:  1993 Apr-Jun       Impact factor: 2.583

7.  Measuring quality of life in asthma.

Authors:  E F Juniper; G H Guyatt; P J Ferrie; L E Griffith
Journal:  Am Rev Respir Dis       Date:  1993-04

8.  Quality of life as a vital clinical sign.

Authors:  B W Kong; J Clive; S H Kong
Journal:  J Hum Hypertens       Date:  1990-04       Impact factor: 3.012

9.  Health status assessment in a hypertension section of an internal medicine clinic.

Authors:  M A Krousel-Wood; R N Re
Journal:  Am J Med Sci       Date:  1994-10       Impact factor: 2.378

10.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.